| The relationship between cure depth and transmission coefficient of visible-light-activated resin composites M Kawaguchi, T Fukushima, K Miyazaki Journal of dental research 73 (2), 516-521, 1994 | 223 | 1994 |
| Mechanisms of hepatocyte growth factor activation in cancer tissues M Kawaguchi, H Kataoka Cancers 6 (4), 1890-1904, 2014 | 117 | 2014 |
| Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo H Kataoka, M Kawaguchi The FEBS journal 277 (10), 2230-2237, 2010 | 93 | 2010 |
| Thymic stromal chemokine TSLP acts through Th2 cytokine production to induce cutaneous T-cell lymphoma N Takahashi, M Sugaya, H Suga, T Oka, M Kawaguchi, T Miyagaki, ... Cancer research 76 (21), 6241-6252, 2016 | 92 | 2016 |
| Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair … K Nagaike, M Kawaguchi, N Takeda, T Fukushima, A Sawaguchi, ... The American journal of pathology 173 (5), 1464-1475, 2008 | 75 | 2008 |
| Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma H Suga, M Sugaya, T Miyagaki, H Ohmatsu, M Kawaguchi, N Takahashi, ... Clinical cancer research 20 (16), 4339-4348, 2014 | 62 | 2014 |
| Hepatocyte growth factor activator inhibitors (HAI‐1 and HAI‐2): emerging key players in epithelial integrity and cancer H Kataoka, M Kawaguchi, T Fukushima, T Shimomura Pathology international 68 (3), 145-158, 2018 | 56 | 2018 |
| Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity M Kawaguchi, N Takeda, S Hoshiko, K Yorita, T Baba, A Sawaguchi, ... The American journal of pathology 179 (4), 1815-1826, 2011 | 52 | 2011 |
| Hepatocyte growth factor activator inhibitor type 1 is a suppressor of intestinal tumorigenesis S Hoshiko, M Kawaguchi, T Fukushima, Y Haruyama, K Yorita, H Tanaka, ... Cancer research 73 (8), 2659-2670, 2013 | 50 | 2013 |
| Hepatocyte growth factor activator is a serum activator of single‐chain precursor macrophage‐stimulating protein M Kawaguchi, H Orikawa, T Baba, T Fukushima, H Kataoka The FEBS journal 276 (13), 3481-3490, 2009 | 50 | 2009 |
| Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model J Ye, M Kawaguchi, Y Haruyama, A Kanemaru, T Fukushima, ... Cancer science 105 (1), 44-51, 2014 | 44 | 2014 |
| Amino acid sequence of the calcium-binding light chain of myosin from the lower eukaryote, Physarum polycephalum. T Kobayashi, T Takagi, K Konishi, Y Hamada, M Kawaguchi, K Kohama Journal of Biological Chemistry 263 (1), 305-313, 1988 | 44 | 1988 |
| Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma T Fukushima, M Kawaguchi, K Yorita, H Tanaka, H Takeshima, ... Neuro-Oncology 14 (1), 19-28, 2012 | 41 | 2012 |
| Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma A Ohno, K Yorita, Y Haruyama, K Kondo, A Kato, T Ohtomo, M Kawaguchi, ... Liver International 34 (6), 942-952, 2014 | 38 | 2014 |
| Loss of membrane‐bound serine protease inhibitor HAI‐1 induces oral squamous cell carcinoma cells' invasiveness T Baba, M Kawaguchi, T Fukushima, Y Sato, H Orikawa, K Yorita, ... The Journal of pathology 228 (2), 181-192, 2012 | 38 | 2012 |
| Ghrelin administration suppresses inflammation‐associated colorectal carcinogenesis in mice M Kawaguchi, A Kanemaru, T Fukushima, K Yamamoto, H Tanaka, ... Cancer science 106 (9), 1130-1136, 2015 | 34 | 2015 |
| HAI‐2 stabilizes, inhibits and regulates SEA‐cleavage‐dependent secretory transport of matriptase AW Nonboe, O Krigslund, C Soendergaard, S Skovbjerg, S Friis, ... Traffic 18 (6), 378-391, 2017 | 30 | 2017 |
| Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer‐associated fibroblasts by paracrine activation of protease‐activated receptor 2 A Kanemaru, K Yamamoto, M Kawaguchi, T Fukushima, CY Lin, ... International Journal of Cancer 140 (1), 130-141, 2017 | 30 | 2017 |
| Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells T Fukushima, M Kawaguchi, M Yamasaki, H Tanaka, K Yorita, H Kataoka Cancer science 102 (2), 407-413, 2011 | 28 | 2011 |
| Hepatocyte Growth Factor Activator Inhibitor Type 1 Maintains the Assembly of Keratin into Desmosomes in Keratinocytes by Regulating Protease-Activated Receptor 2–Dependent p38 … M Kawaguchi, A Kanemaru, A Sawaguchi, K Yamamoto, T Baba, CY Lin, ... The American Journal of Pathology 185 (6), 1610-1623, 2015 | 25 | 2015 |
